Representative before the EPO

Employment test 201 - 500 employees
Company dna awapatent
operating since 1897
1191.27
Headquarter in Malmö and 14 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 15 EP applications Inga-Lill Andersson has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after February 23, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11823854

FIXATION DEVICE

IPC classification:
A61F 13/02, A61M 25/02
Applicant:
Mölnlycke Health Care AB
Agent:
Inga-Lill Andersson, Awapatent AB
Agent:
Maria Börlin, Zacco Sweden AB
Status:
GRANT OF PATENT INTENDED
EP11181961

Polymer fibers

IPC classification:
A61L 15/22, A61L 15/26, D01D 5/08, D01F 1/10, D01F 6/70, D01F 6/94
Applicant:
Mölnlycke Health Care AB
Agent:
Inga-Lill Andersson, Awapatent AB
Agent:
Maria Börlin, Zacco Sweden AB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12164095

Organic Field-Effect Transistor Device

IPC classification:
H01L 51/05
Applicant:
Acreo Swedish ICT AB
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12814751

METHODS FOR DIAGNOSING AND TREATING ALZHEIMER'S DISEASE BY ADMINISTERING AN ANGIOGENIC AGENT

IPC classification:
A61K 38/17, A61K 39/395, A61P 25/28, C07K 14/47
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
EXAMINATION IN PROGRESS
EP12769059

POLYMER FIBRE

IPC classification:
A61L 15/22, A61L 15/26, D01D 5/08, D01F 1/10, D01F 6/70, D01F 6/94
Applicant:
Mölnlycke Health Care AB
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
GRANT OF PATENT INTENDED
EP13701040

TETRAHYDROFOLATES IN COMBINATION WITH EGFR-INHIBITORS

IPC classification:
A61K 31/519, A61K 39/395, A61K 45/06, A61P 35/00
Applicant:
Isofol Medical AB
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
EXAMINATION IN PROGRESS
EP13700418

ANTI-TUMOR ACTIVITY OF REDUCED FOLATES LIKE METHYLENE-TETRAHYDROFOLATE

IPC classification:
A61K 31/519, A61P 35/00
Applicant:
Isofol Medical AB
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12199049

Silicone film

IPC classification:
A61L 24/04
Applicant:
Mölnlycke Health Care AB
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
PATENT GRANTED
EP12717851

BIOSENSOR HAVING NANOSTRUCURED ELECTRODES

IPC classification:
B82Y 15/00, B82Y 30/00
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
GRANT OF PATENT INTENDED
EP13775009

METHODS FOR BLADDER CANCER THERAPY USING BACULOVIRAL VECTORS

IPC classification:
A61K 31/7088, A61K 35/76, A61P 35/00, C12N 15/86
Applicant:
Agency for Science, Technology and Research
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
EXAMINATION IN PROGRESS
EP13737672

SUBSTITUTED HETERO-BICYCLIC COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF

IPC classification:
A61K 31/519, A61P 19/02, C07D 403/14, C07D 413/14
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
PATENT GRANTED
EP13819944

IN VITRO ASSAY FOR PREDICTING RENAL PROXIMAL TUBULAR CELL TOXICITY

IPC classification:
C12Q 1/06, G01N 33/483, G01N 33/533
Applicant:
Agency for Science, Technology and Research
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
The patent has been granted
EP13811956

SILICONE FILM

IPC classification:
A61L 24/04
Applicant:
Mölnlycke Health Care AB
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
GRANT OF PATENT INTENDED
EP14745832

BIOMARKERS FOR INFLAMMATORY BOWEL DISEASE WITH ANKYLOSING SPONDYLITIS

IPC classification:
G01N 33/564
Applicant:
University Health Network (UHN)
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14745446

J-AGGREGATE FORMING NANOPARTICLE

IPC classification:
A61K 47/22, A61K 47/24, A61K 49/00, A61K 49/22
Applicant:
University Health Network (UHN)
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature